This strategic move aims to address the increasing global demand for biologics, enhancing ProBioGen's ability to support partners from cell line development t
Biologics manufacturing to expand the Aragen platform by offering “gene to GMP” solution
The integrated services ensure that NextPoint can bring their molecule to the clinic in a timely manner.
The new program includes upstream and downstream process development and large-scale GMP production.
Support for bioprocess, cell and gene therapy, and industry 4.0 initiatives
This expansion will support the global operations network and help meet global demand for mammalian development services that support Lonza’s manufacturing sites
With a mix of vaccines targeting different stages of COVID-19, the company is eyeing huge market potential
Subscribe To Our Newsletter & Stay Updated
